InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.690 0.005 (0.72%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$188 Institutional Component of US Led Placement Completed 19 Nov 2015 6:53PM $0.515 $0.690 risen by 33.98%
$188 Appendix 3B 19 Nov 2015 6:34PM $0.515 $0.690 risen by 33.98%
$188 First Singapore Patient Receives Cartilage Therapy Ortho-ACI 18 Nov 2015 9:18AM $0.490 $0.690 risen by 40.82%
$188 Orthocell to raise up to $4.4 million in US Led Placement 17 Nov 2015 10:35AM $0.535 $0.690 risen by 28.97%
$188 Trading Halt 16 Nov 2015 9:27AM $0.535 $0.690 risen by 28.97%
$188 Positive Initial Results Using Celgro in Dental Study 10 Nov 2015 8:25AM $0.530 $0.690 risen by 30.19%
$188 Appendix 4C - quarterly 30 Oct 2015 6:17PM $0.595 $0.690 risen by 15.97%
$188 Ortho-ATI Tendon Treatment Positive in Workers Comp Study 28 Oct 2015 9:34AM $0.595 $0.690 risen by 15.97%
$188 Appendix 4G 27 Oct 2015 7:44PM $0.595 $0.690 risen by 15.97%
$188 Annual Report to shareholders 27 Oct 2015 7:36PM $0.595 $0.690 risen by 15.97%
$188 Notice of Annual General Meeting/Proxy Form 27 Oct 2015 7:34PM $0.595 $0.690 risen by 15.97%
$188 Tendon Regeneration Data Presented at South Africa Meeting 22 Oct 2015 9:53AM $0.600 $0.690 risen by 15%
$188 Technology and Data Presentations at key Ortho Conferences 15 Oct 2015 11:40AM $0.620 $0.690 risen by 11.29%
$188 Orthocell Presents at Stem Cell Meeting on the Mesa 8 Oct 2015 8:24AM $0.650 $0.690 risen by 6.15%
$188 Investor Presentation 23 Sep 2015 8:28AM $0.635 $0.690 risen by 8.66%
$188 Full Year Statutory Accounts 18 Sep 2015 7:07PM $0.650 $0.690 risen by 6.15%
$188 Further Details to Cell Factory Announcement and Update 16 Sep 2015 9:29AM $0.580 $0.690 risen by 18.97%
$188 Orthocells Cell Factory validated for bone regeneration 15 Sep 2015 9:27AM $0.530 $0.690 risen by 30.19%
$188 Preliminary Final Report 28 Aug 2015 6:16PM $0.610 $0.690 risen by 13.11%
$188 Orthocell Holds Inaugural User Group Meeting 11 Aug 2015 10:18AM $0.845 $0.690 fallen by 18.34%
$188 Appendix 4C - quarterly 31 Jul 2015 5:09PM $0.720 $0.690 fallen by 4.17%
$188 Response to ASX Aware Query 27 Jul 2015 11:38AM $0.860 $0.690 fallen by 19.77%
$188 Release of Securities from Escrow 17 Jul 2015 5:17PM $0.560 $0.690 risen by 23.21%
$188 Pipeline Cartilage Product Validated in Leading Publication 16 Jul 2015 10:15AM $0.465 $0.690 risen by 48.39%
$188 Grant for World First Laboratory Grown Tendon Received 9 Jul 2015 10:01AM $0.380 $0.690 risen by 81.58%

726 - 750 of 771 results

Page 30 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.